Declaration. Truisms What We All Think We Know About High Blood Pressure May Not Be True
Truisms — What We All Think We Know About High Blood Pressure May Not Be True
Truisms — What We All Think We Know About High Blood Pressure May Not B...
Truisms — What We All Think We Know About High Blood Pressure May Not Be True
Truisms — What We All Think We Know About High Blood Pressure May Not Be True
BP thresholds and targets in the treatment of hypertension. An evidence-based approach
Montreal April 2015 James (Jim) Wright Therapeutics Initiative (TI)
Declaration No financial competing interests. Professor University of BC Co-Managing Director of TI Editor-in-Chief, Therapeutics Letter Coordinating Editor, Cochrane Hypertension Group Half-day a week outpatient Clinical Pharmacology practice.
An evidence-based approach to practical clinical scenarios What is the evidence for treating moderate to severe hypertension (>160/100 mmHg)?
What is the optimal target blood pressure? Treatment of hypertension in the very elderly (>80 yrs).
What is the evidence for treating mild elevations in blood pressure (140-159/90-99 mmHg)?
Clinical Implications Relevant to people 60 and over with moderate to severe elevations of BP (>160/100 mmHg).
Most patients were primary prevention and treated with stepped care therapy starting with a thiazide.
40% of patients failed to achieve target diastolic of 160 mmHg. (Threshold for treatment).
Total mortality – self evident
I–
SAEs include any untoward medical occurrence that
Antihypertensive drug treatment.
C – Placebo or no treatment. O – Hierarchy of clinically important outcomes.
Total serious adverse events (SAEs) results in death, is life-threatening, requires hospitalization or prolongation of hospitalization, or results in persistent or significant disability.*
S – Randomized clinical trials (at least 1 year duration).
Total Mortality and SAEs provide a measure of net effect.
Hierarchy of health outcomes Total mortality Total people with at least one serious adverse event
Benefit
Total cardiovascular SAEs (fatal and non-fatal stroke, fatal and non-fatal MI and fatal and non-fatal CHF)
Achieved differences in blood pressure.
Harm
264
Truisms — What We All Think We Know About High Blood Pressure May Not Be True
Cochrane Library Musini VM, Tejani AM, Bassett K, Wright JM. Pharmacotherapy for hypertension in the elderly. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD000028. DOI: 10.1002/14651858.CD000028.pub2.
ARR = 1299/11166 (0.1) (100) =1.2%, NNT=83 for 5 yrs.
Clinical Implications Relevant to people 60 and over with moderate to severe elevations of BP (>160/100 mmHg, including isolated systolic hypertension.
Most patients were primary prevention and treated with stepped care therapy starting with a thiazide.
40% of patients failed to achieve target diastolic of